Search

everythinglearnresearchcommunity

for

Search:↓

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Adult acne is often related to hormonal disorders, especially in women, and may need long-term treatment involving specialists.

Insulin resistance increases the risk of developing type 2 diabetes and other health issues.

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.

Understanding how acne develops in different diseases could lead to new treatments.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

The research suggests new treatments for skin cancer could target specific cell growth pathways.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Doctors used a special blood sampling technique to diagnose a woman's rare ovarian tumor that was producing male hormones.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

A woman with a rare adrenal tumor and hormonal disorder had improved testosterone levels after surgery, but her menstrual irregularities continued.

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

A thorough diagnostic process and teamwork are crucial for managing complex hyperandrogenism in postmenopausal women.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Certain hair straighteners and dyes may increase ovarian cancer risk, especially in African American/Black women.

Iron deficiency may contribute to hair loss.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

The document concludes that personalized treatment, including lifestyle changes and medication, is essential for managing PCOS in teenagers, while also addressing their psychological well-being.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Eating certain seeds may help reduce symptoms of Polycystic Ovary Syndrome.

PCOS and related metabolic issues often run in families.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.